Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Adiponectin and all-cause mortality in elderly people with type 2 diabetes.

Singer JR, Palmas W, Teresi J, Weinstock R, Shea S, Luchsinger JA.

Diabetes Care. 2012 Sep;35(9):1858-63. doi: 10.2337/dc11-2215. Epub 2012 Jul 6.

2.

Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes.

Forsblom C, Thomas MC, Moran J, Saraheimo M, Thorn L, Wadén J, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group.

J Intern Med. 2011 Oct;270(4):346-55. doi: 10.1111/j.1365-2796.2011.02406.x. Epub 2011 Jun 23.

3.

Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus.

Kanazawa I, Yamaguchi T, Sugimoto T.

Metabolism. 2010 Sep;59(9):1252-6. doi: 10.1016/j.metabol.2009.11.017. Epub 2010 Jan 4.

PMID:
20045535
4.

Inverse relationship of serum adiponectin concentration with type 2 diabetes mellitus incidence in middle-aged Japanese workers: six-year follow-up.

Li Y, Yatsuya H, Iso H, Toyoshima H, Tamakoshi K.

Diabetes Metab Res Rev. 2012 May;28(4):349-56. doi: 10.1002/dmrr.2277.

PMID:
22228701
5.
6.

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM.

Diabetes Care. 2006 Nov;29(11):2498-503.

PMID:
17065691
7.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
8.

Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study.

Ong G, Davis WA, Davis TM.

Diabetologia. 2010 Jul;53(7):1288-94. doi: 10.1007/s00125-010-1735-7. Epub 2010 Mar 30.

PMID:
20349345
9.

Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.

Graessler J, Gruber M, Radke RB, Kopprasch S, Schwarz PE, Kamke W, Bornstein SR, Fischer S.

Gerontology. 2011;57(4):316-26. doi: 10.1159/000316575. Epub 2010 Jun 11.

PMID:
20551622
10.

The impact of treatment noncompliance on mortality in people with type 2 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

Diabetes Care. 2012 Jun;35(6):1279-84. doi: 10.2337/dc11-1277. Epub 2012 Apr 17.

11.

The ratio of leptin to adiponectin can be used as an index of insulin resistance.

Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M.

Metabolism. 2008 Feb;57(2):268-73. doi: 10.1016/j.metabol.2007.09.011.

PMID:
18191059
12.

Elevation of serum high molecular weight adiponectin in patients with Type 2 diabetes and orthostatic hypotension: association with arterial stiffness and hypercoagulability.

Aso Y, Wakabayashi S, Terasawa T, Naruse R, Hara K, Takebayashi K, Inukai T.

Diabet Med. 2012 Jan;29(1):80-7. doi: 10.1111/j.1464-5491.2011.03364.x.

PMID:
22082489
13.

Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study).

Lindberg S, Mogelvang R, Pedersen SH, Bjerre M, Frystyk J, Flyvbjerg A, Galatius S, Jensen JS.

Am J Cardiol. 2013 Apr 15;111(8):1139-45. doi: 10.1016/j.amjcard.2012.12.043. Epub 2013 Feb 1.

PMID:
23375598
14.

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes.

Aso Y, Hara K, Ozeki N, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Haruki K, Inukai T.

Diabetes Res Clin Pract. 2009 Aug;85(2):147-52. doi: 10.1016/j.diabres.2009.05.015. Epub 2009 Jun 21.

PMID:
19545925
15.

Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.

Bo S, Castiglione A, Ghigo E, Gentile L, Durazzo M, Cavallo-Perin P, Ciccone G.

Eur J Endocrinol. 2013 Jun 7;169(1):117-26. doi: 10.1530/EJE-13-0299. Print 2013 Jul.

16.

Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study.

Siitonen N, Pulkkinen L, Lindström J, Kolehmainen M, Eriksson JG, Venojärvi M, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M.

BMC Med Genet. 2011 Jan 10;12:5. doi: 10.1186/1471-2350-12-5.

17.

Social deprivation and mortality in adults with diabetes mellitus.

Robinson N, Lloyd CE, Stevens LK.

Diabet Med. 1998 Mar;15(3):205-12.

PMID:
9545121
18.

Three-month treatment with pioglitazone reduces circulating C1q-binding adiponectin complex to total-adiponectin ratio, without changes in body mass index, in people with type 2 diabetes.

Nakatsuji H, Kishida K, Kobayashi H, Funahashi T, Shimomura I; Senri Study II Group.

Diabetes Res Clin Pract. 2013 Jan;99(1):e14-7. doi: 10.1016/j.diabres.2012.10.003. Epub 2012 Nov 9.

PMID:
23142017
19.

Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.

Yun JE, Sull JW, Lee HY, Park E, Kim S, Jo J, Lee SJ, Kim SY, Choi YJ, Jee SH, Huh KB.

Diabetes Metab Res Rev. 2009 Mar;25(3):259-65. doi: 10.1002/dmrr.946.

PMID:
19214966
20.
Items per page

Supplemental Content

Write to the Help Desk